Home / Inspections / 980976

FDA Inspection 980976 — Jamol Laboratories, Inc.

Jamol Laboratories, Inc. — FEI 2211383

The FDA completed an inspection of Jamol Laboratories, Inc. on August 3, 2016 in Emerson, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 3, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Emerson, NJ (United States)

Facility

Other inspections at this facility

  • 1256416 (OAI Thu Dec 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1195290 (OAI Thu Jan 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 828881 (NAI Wed Apr 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 715900 (NAI Mon Mar 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources